Factors Influencing Human Papillomavirus School-based Immunization in Alberta: A Mixed-methods Study Protocol

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Dec 1

PMID 36454791

Authors

Jennifer Malkin

Lisa Allen Scott

Amanda Alberga Machado

Gary Teare

Joanne Snider

Syed Farhan Ali Tirmizi

Thilina Bandara

Mika Rathwell

Cordell Neudorf

Affiliations

Soon will be listed here.

Abstract

More than 1,300 Canadians are diagnosed with cervical cancer annually, which is nearly preventable through human papillomavirus (HPV) immunization. Across Canada, coverage rates remain below the 90% target set out by the Action Plan for the Elimination of Cervical Cancer in Canada (2020-2030). To support this Plan, the Canadian Partnership Against Cancer has commissioned the Urban Public Health Network (UPHN) to coordinate a quality improvement project with Canada's school-based HPV immunization programs. In Alberta, the UPHN partnered with Alberta Health Services (AHS) for this work. This study has one overarching research question: what are parent/guardian and program stakeholder perceived barriers, enablers and opportunities to immunization for youth as part of the school-based HPV immunization program in Alberta? This study uses a mixed-methods sequential explanatory design. A survey will be emailed to a sample of Albertans with children aged 11-17 years. Questions will be based on a Conceptual Framework of Access to Health Care. Subsequent qualitative work will explore the survey's findings. Parents/guardians identifying as vaccine hesitant in the survey will be invited to participate in virtual, semi-structured, in-depth interviews. Stakeholders of the school-based immunization program will be purposively sampled from AHS' five health zones for virtual focus groups. Quantitative data will be analyzed using SAS Studio 3.6 to carry out descriptive statistics and, using logistic regression, investigate if Framework constructs are associated with parents'/guardians' decision to immunize their children. Qualitative data will be analyzed using NVivo 12 to conduct template thematic analysis guided by the Framework. Study results will provide insights for Alberta's public health practitioners to make evidence-informed decisions when tailoring the school-based HPV immunization program to increase uptake in vaccine hesitant populations. Findings will contribute to the national study, which will culminate in recommendations to increase HPV immunization uptake nationally and progress towards the 90% coverage target.

Citing Articles

Individual and Geospatial Determinants of Health Associated With School-Based Human Papillomavirus Immunization in Alberta: Population-Based Cohort Study.

Malkin J, Jessiman-Perreault G, Alberga Machado A, Teare G, Snider J, Tirmizi S JMIR Public Health Surveill. 2024; 10():e45508.

PMID: 38536211 PMC: 11007603. DOI: 10.2196/45508.

References

Davies C, Stoney T, Hutton H, Parrella A, Kang M, Macartney K . School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination. Vaccine. 2021; 39(30):4190-4198. DOI: 10.1016/j.vaccine.2021.05.051. View

Liu X, Bell C, Simmonds K, Russell M, Svenson L . HPV Vaccine utilization, Alberta 2008/09-2013/14 School year. BMC Infect Dis. 2016; 16:15. PMC: 4711033. DOI: 10.1186/s12879-016-1340-6. View

Stout M, Christy S, Winger J, Vadaparampil S, Mosher C . Self-efficacy and HPV Vaccine Attitudes Mediate the Relationship Between Social Norms and Intentions to Receive the HPV Vaccine Among College Students. J Community Health. 2020; 45(6):1187-1195. PMC: 7606315. DOI: 10.1007/s10900-020-00837-5. View

Larson H, Jarrett C, Schulz W, Chaudhuri M, Zhou Y, Dube E . Measuring vaccine hesitancy: The development of a survey tool. Vaccine. 2015; 33(34):4165-75. DOI: 10.1016/j.vaccine.2015.04.037. View

Williams C, Walker T, Elam-Evans L, Yankey D, Fredua B, Saraiya M . Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey-Teen, 2016-2017. Hum Vaccin Immunother. 2019; 16(3):562-572. PMC: 7227662. DOI: 10.1080/21645515.2019.1670036. View

Crosby R, Casey B, Vanderpool R, Collins T, Moore G . Uptake of free HPV vaccination among young women: a comparison of rural versus urban rates. J Rural Health. 2011; 27(4):380-4. PMC: 4753792. DOI: 10.1111/j.1748-0361.2010.00354.x. View

Gust D, Kennedy A, Shui I, Smith P, Nowak G, Pickering L . Parent attitudes toward immunizations and healthcare providers the role of information. Am J Prev Med. 2005; 29(2):105-12. DOI: 10.1016/j.amepre.2005.04.010. View

Chatterjee A . The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon. Expert Rev Vaccines. 2014; 13(11):1279-90. DOI: 10.1586/14760584.2014.963561. View

Gottvall M, Tyden T, Larsson M, Stenhammar C, Hoglund A . Challenges and opportunities of a new HPV immunization program perceptions among Swedish school nurses. Vaccine. 2011; 29(28):4576-83. DOI: 10.1016/j.vaccine.2011.04.054. View

10.

Helmkamp L, Szilagyi P, Zimet G, Saville A, Gurfinkel D, Albertin C . A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines. Vaccine. 2021; 39(13):1831-1839. DOI: 10.1016/j.vaccine.2021.02.039. View

11.

Dube E, Gagnon D, Clement P, Bettinger J, Comeau J, Deeks S . Challenges and opportunities of school-based HPV vaccination in Canada. Hum Vaccin Immunother. 2019; 15(7-8):1650-1655. PMC: 6746476. DOI: 10.1080/21645515.2018.1564440. View

12.

Bair R, Mays R, Sturm L, Zimet G . Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol. 2008; 21(6):329-34. DOI: 10.1016/j.jpag.2008.02.007. View

13.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

14.

Selvey L, Roux F, Burns S . Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake. Vaccine. 2020; 38(14):2971-2977. DOI: 10.1016/j.vaccine.2020.02.047. View

15.

Remes O, Smith L, Alvarado-Llano B, Colley L, Levesque L . Individual- and regional-level determinants of human papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study. BMC Public Health. 2014; 14:1047. PMC: 4210569. DOI: 10.1186/1471-2458-14-1047. View

16.

Piche-Renaud P, Ji C, Farrar D, Friedman J, Science M, Kitai I . Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada. Vaccine. 2021; 39(31):4373-4382. PMC: 9756828. DOI: 10.1016/j.vaccine.2021.05.094. View

17.

Bolarinwa O . Principles and methods of validity and reliability testing of questionnaires used in social and health science researches. Niger Postgrad Med J. 2016; 22(4):195-201. DOI: 10.4103/1117-1936.173959. View

18.

Sell H, Paudel Y, Voaklander D, MacDonald S . School immunization coverage in adolescents during the COVID-19 pandemic: A retrospective cohort study. Vaccine. 2023; 41(7):1333-1341. PMC: 9826994. DOI: 10.1016/j.vaccine.2023.01.011. View

19.

Fisher W, Kohut T, Salisbury C, Salvadori M . Understanding human papillomavirus vaccination intentions: comparative utility of the theory of reasoned action and the theory of planned behavior in vaccine target age women and men. J Sex Med. 2013; 10(10):2455-64. DOI: 10.1111/jsm.12211. View

20.

Perman S, Turner S, Ramsay A, Baim-Lance A, Utley M, Fulop N . School-based vaccination programmes: a systematic review of the evidence on organisation and delivery in high income countries. BMC Public Health. 2017; 17(1):252. PMC: 5348876. DOI: 10.1186/s12889-017-4168-0. View